Skip to main content
. 2023 Mar 31;14:1077590. doi: 10.3389/fendo.2023.1077590

Table 2.

Distributions of serum fatty acids in various PCOS subtypes.

HA subtype
(n=50)		 Non-HA subtype
(n=144)		 P P-adja Reproductive subtypes
(n=55)		 Metabolic subtypes
(n=65)		 P P-adjb
Age (years) 30.32 ± 4.2 30.89 ± 3.4 0.343 – 30.65 ± 3.5 30.42 ± 3.9 0.726 –
BMI (kg/m2) 26.24 ± 5.7 24.69 ± 4.2 0.043 – 23.46 ± 3.7 24.35 ± 4.2 0.277 –
Log10total SFAs (μg/mL) 3.19 ± 0.11 3.16 ± 0.10 0.074 0.087 3.16 ± 0.10 3.17 ± 0.11 0.713 0.715
Log10total MUFAs (μg/mL) 2.51 ± 0.18 2.47 ± 0.17 0.099 0.154 2.42 ± 0.14 2.49 ± 0.15 0.016 0.018
Log10total TFAs (μg/mL) 1.78 ± 0.25 1.78 ± 0.30 0.997 0.924 1.74 ± 0.23 1.79 ± 0.21 0.282 0.287
Log10total PUFAs (μg/mL) 2.60 ± 0.15 2.56 ± 0.16 0.143 0.166 2.52 ± 0.15 2.59 ± 0.15 0.009 0.012
Log10n-3 PUFA (μg/mL) 1.61 ± 0.15 1.57 ± 0.17 0.152 0.139 1.54 ± 0.16 1.60 ± 0.16 0.027 0.029
Log10n-6 PUFA (μg/mL) 2.51 ± 0.16 2.55 ± 0.15 0.146 0.174 2.47 ± 0.16 2.55 ± 0.15 0.009 0.012

PCOS, polycystic ovary syndrome; HA, hyperandrogenism; P-adja, Padjusted by age and BMI; P-adjb, Padjusted by age; SFAs, saturated fatty acids; MUFAs, monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids; TFAs, trans fatty acids.